Substance P-induced release of Met5-enkephalin from striatal and periaqueductal gray slices.
Substance P(SP), the heptapeptide SP and the stable analogue (p-Glu5-MePhe8-MeGly9) SP (DiMe-C7) induce a Ca2+-dependent release of Met5-enkephalin (MET) from slices of periaqueductal gray matter (PAG) and striatum of rats. The MET release from striatal slices is greater than that from PAG slices because of the higher MET content of striatum. Intraventricular injection of SP and of the two related peptides induce analgesia in the rat, and their analgesic potency is in line with their capacity to release MET. Other neuropeptides which possess antinociceptive activity such as bombesin, neurotensin, vasopressin and somatostatin fail to release MET from PAG slices.
D000818:Animals; D001127:Arginine Vasopressin / Q000494:pharmacology; D001839:Bombesin / Q000494:pharmacology; D003342:Corpus Striatum / Q000187:drug effects* / Q000378:metabolism; D004305:Dose-Response Relationship, Drug; D004744:Enkephalin, Methionine / Q000378:metabolism*; D008297:Male; D009270:Naloxone / Q000494:pharmacology; D009496:Neurotensin / Q000494:pharmacology; D009619:Nociceptors / Q000187:drug effects; D010446:Peptide Fragments / Q000494:pharmacology; D010487:Periaqueductal Gray / Q000187:drug effects* / Q000378:metabolism; D011761:Pyrrolidonecarboxylic Acid / Q000031:analogs & derivatives; D051381:Rats; D011919:Rats, Inbred Strains; D012684:Sensory Thresholds; D013373:Substance P / Q000031:analogs & derivatives / Q000494:pharmacology*
D010446:Peptide Fragments; D001127:Arginine Vasopressin; D013373:Substance P; D009270:Naloxone; D009496:Neurotensin; C031661:substance P (5-11); D004744:Enkephalin, Methionine; C032720:substance P (5-11), pGlu(5)-MePhe(8)-MeGly(9)-; D001839:Bombesin; D011761:Pyrrolidonecarboxylic Acid